My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 758 / DOI: 10.3332/ecancer.2017.758

Case Report

Metastasizing pleomorphic adenoma of the parotid gland

Salivary gland tumours are estimated to represent approximately 3% of all head and neck tumours. About 70–80% of these neoplasms occur in the major salivary glands, with the parotid gland being the most commonly affected site. The metastasizing pleomorphic adenoma (MPA) has histological characteristics of pleomorphic adenoma, but it has the capacity to generate local recurrences and distant metastases (mainly bones, lungs, and lymph nodes). Despite the fact that some authors consider it to be a benign neoplasia, the 2015 World Health Organisation (WHO) classification of head and neck tumours considers it to be malignant.

We present a highly unusual case of metastasizing pleomorphic adenoma of the parotid gland and a bibliographic review.

Keywords: metastasizing pleomorphic adenoma, salivary glands, parotid gland, adenoma, case report, bibliographic review

Loading Article Metrics ... Please wait

Related articles

Case Report: Unusual case of splenic sarcoidosis without morphological lesions detected by PET-CT in a patient with breast cancer: functional imaging between pitfalls and therapeutic guide

Abstract | Full Article | PDF Published: 08 Sep 2017 / DOI: 10.3332/ecancer.2017.766

Case Report: Malignant extra-adrenal pelvic paraganglioma in a paediatric patient

Abstract | Full Article | PDF | Spanish Published: 23 Aug 2017 / DOI: 10.3332/ecancer.2017.761

Case Report: Resection of rectal GIST using a novel technique: a report of two cases

Abstract | Full Article | PDF Published: 17 Aug 2017 / DOI: 10.3332/ecancer.2017.760

Research: Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy

Abstract | Full Article | PDF Published: 15 Aug 2017 / DOI: 10.3332/ecancer.2017.759

Research: Clinical, epidemiological, and therapeutic profile of patients with a retinoblastoma diagnosis experience in the Costa Rica National Children’s Hospital Oncology Unit from January 2009 to December 2015

Abstract | Full Article | PDF Published: 24 Jul 2017 / DOI: 10.3332/ecancer.2017.754



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence